Clinical outcome of central conventional chondrosarcoma
- 30 May 2012
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 106 (8) , 929-937
Abstract
Introduction: Aim of this study was to analyze (1) survival, local recurrence (LR), and metastasis rates between the three histological tumor grades; (2) whether type of treatment and tumor site influenced prognosis for each histologic grade.Methods: We retrospectively studied 296 patients with central conventional chondrosarcomas (CS) (87 grade 1, 162 grade 2, and 47 grade 3). The femur was the most common site (91 cases), followed by the pelvis (82) and other less frequent sites. Type of surgery was related with histologic grade. Margins were wide in 222 cases, marginal in 23, and intralesional in 51 cases.Results: At a mean of 7 years, 201 patients remained continuously NED, 33 were NED after treatment of relapse, 15 were AWD, 35 were died of disease, and 12 of other causes. Survival was 92% at 5 years and 84% at 10 years, significantly influenced by histological grading. In grade 3 CS, two factors influenced survival: type of surgery (resection vs. amputation, P = 0.051) and site (P = 0.039). The two significant factors lost their significance at multivariate analysis.Conclusion: Central conventional CS with low/intermediate grade has a good prognosis, while high‐grade tumors have poor outcome. Tumor relapses are strictly related with histologic grade. J. Surg. Oncol. 2012; 106: 929–937.Keywords
This publication has 55 references indexed in Scilit:
- Chondrosarcoma of Bone: Lessons From 46 Operated Cases in a Single InstitutionClinical Orthopaedics and Related Research, 2010
- No Recurrences in Selected Patients after Curettage with Cryotherapy for Grade I ChondrosarcomasClinical Orthopaedics and Related Research, 2010
- Surgical Treatment of Grade I Central ChondrosarcomaClinical Orthopaedics and Related Research, 2010
- The cytotoxic effect of phenol and ethanol on the chondrosarcoma-derived cell line OUMS-27The Journal of Bone and Joint Surgery. British volume, 2008
- Grade I chondrosarcoma of bone: the Münster experienceJournal of Cancer Research and Clinical Oncology, 2008
- Pathology of primary malignant bone and cartilage tumoursInternational Orthopaedics, 2006
- Grade 2 Chondrosarcoma: Stage I or Stage II Tumor?Clinical Orthopaedics and Related Research, 2003
- Treatment of low-grade chondrosarcomaCurrent Orthopaedic Practice, 2000
- Chondrosarcoma of the pelvis: Prognostic factors for 67 patients treated with definitive surgeryCancer, 1996
- Borderline chondrosarcoma of long and flat bonesJournal of Cancer Research and Clinical Oncology, 1993